6th Edition of International Conference on

Clinical Oncology

Theme: Conquering Cancer with the Latest Advancements in Clinical Oncology

Event Date & Time

Event Location

Frankfurt, Germany

18 years of lifescience communication


Previous Conference Performers / Professionals From Around The Globe

Tracks & Key Topics



With a zeal, we are glad to announce the 6th Edition of International Conference on Clinical Oncology (Clinical Oncology 2020) organized in collaboration with generous support and cooperation from enthusiastic academicians and Editorial Board Members. Clinical Oncology 2020 aims at sharing new ideas and technologies amongst the professionals, industrialists and students from research areas of Oncology. As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting-edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.

Who Should Attend??

Clinical Oncology 2020 Conference is a novel discussion to unite overall recognized scholastic Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars in the field of Oncology, Hematology, Surgery, Nursing, Radiology, Paediatrics, Advocacy, etc., to exchange about the state of the Research and Development.

Target Audience:

  • Oncologists
  • Radiologists
  • Chemotherapists
  • Cancer Institutes
  • Scientists
  • Professors
  • Doctors
  • Medical Colleges
  • Medical Practitioners
  • Diagnostic Laboratory Professionals
  • Students               
  • Nurses
  • Patient Advocates
  • Business Entrepreneurs
  • Industry professionals
  • Marketing, Advertising and Promotion Agency Executives

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

Exclusive B2B meetings, Interactive Sessions, Panel Discussions, Keynote Sessions, Poster Presentations, Oral Presentations, Workshops, Exhibitions etc., are the main highlights of this event.


Frankfurt is the biggest city of the German government province of Hesse, and its 746,878 occupants make it the fifth-biggest city of Germany after Berlin, Hamburg, Munich, and Cologne. On the River Main (a tributary of the Rhine), it frames a ceaseless conurbation with the neighbouring city of Offenbach am Main, and its urban zone has a populace of 2.3 million. The city is at the focal point of the bigger Rhine-Main Metropolitan Region, which has a populace of 5.5 million and is Germany's second-biggest metropolitan district after the Rhine-Ruhr Region. Since the broadening of the European Union in 2013, the geographic focus of the EU is around 40 km (25 mi) toward the east of Frankfurt's focal business locale. Like France and Franconia, the city is named after the Franks. Frankfurt is the biggest city in the Rhine Franconian lingo region (West Central German).

Frankfurt is an alpha world city and a worldwide centre point for business, culture, training, the travel industry and transportation. It is the site of numerous worldwide and European corporate central commands. Frankfurt Airport is among the world’s busiest. Frankfurt is the major money related focal point of the European landmass, with the home office of the European Central Bank, Deutsche Bundesbank, Frankfurt Stock Exchange, Deutsche Bank, DZ Bank, KfW, Commerzbank, a few cloud and fintech start-ups and different establishments. Car, innovation and research, administrations, counselling, media and inventive enterprises supplement the financial base. Frankfurt's DE-CIX is the world's biggest web trade point. Messe Frankfurt is one of the world's biggest exchange fairs. Real fairs incorporate the Frankfurt Motor Show, the world's biggest engine appear, the Music Fair, and the Frankfurt Book Fair, the world's biggest book reasonable.

Frankfurt attractions:

  • Römerberg
  • Main Tower
  • Goethe House
  • Dinosaur Skeleton
  • Sachsenhausen
  • Paulskirche
  • Spend an Afternoon Admiring Fine Art
  • Palmengarten
  • Fifth Avenue of Germany
  • Admire Modern Architecture and Art
  • Museum




Cancer is a disease characterized by uncontrolled cell proliferation. There are more than 100 types of cancer. The most common causes of cancer death are cancers of Lung (1.69 million deaths), Liver (788 000 deaths), Colorectal (774 000 deaths), Stomach (754 000 deaths) and Breast (571 000 deaths) which accounts for nearly half of new cases per year. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

The kinds of cancer we expect to increase the most are

  • Melanoma (the deadliest kind of skin cancer) in white men and women.
  • Prostate, kidney, liver, and bladder cancers in men.
  • Lung, breast, uterine, and thyroid cancers in women.

Cancer is among the leading causes of death worldwide. In 2012, there were 14.1 million new cases and 8.2 million cancer-related deaths worldwide. The number of new cancer cases per year is expected to rise to 23.6 million by 2030. The most recent SEER Cancer Statistics Review, released in April 2019, shows that cancer death rates decreased by 1.8% per year among men from 2006 to 2015, 1.4% per year among women from 2006 to 2015 and 1.4% per year among children ages 0–19 from 2011 to 2015.

Global Oncology/Cancer drugs Market is expected to garner $111,938.4 million by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for cancer treatment with the identification of tumour cell specific genes. The number of approved cancer therapies continues to rise. The continued rise and impact of immuno-oncology has been largely centred on the PD-1 and PD-L1 checkpoint inhibitors, which have broad efficacy across solid tumours and are used across 23 different tumour types. Overall, the global market for oncology therapeutic medicines will reach as much as $200 billion by 2022, averaging 10—13% growth over the next five years, with the U.S. market reaching as much as $100 billion by 2022, averaging 12–15% growth.


Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!